Literature DB >> 15735008

Oncogenic K-RAS is required to maintain changes in cytoskeletal organization, adhesion, and motility in colon cancer cells.

Claire B Pollock1, Senji Shirasawa, Takehiko Sasazuki, Walter Kolch, Amardeep S Dhillon.   

Abstract

RAS oncogenes are thought to play a role at multiple stages of tumorigenesis. The role and mechanisms by which RAS oncogenes maintain the transformed state of human cancer cells are poorly understood. Here, we have studied the role of oncogenic K-RAS in maintaining cytoskeletal disruption, cell adhesion and motility in metastatic colon carcinoma cells. Targeted deletion of K-RAS(G13D) from HCT116 colon carcinoma cells restored their ability to assemble stress fibers and focal adhesions/complexes, accompanied by increased cell-matrix adhesion and reduced motility. We further show that oncogenic K-Ras induces high Rho activity, but uncouples Rho from stress fiber formation. This uncoupling required the maintenance of high levels of the activator protein-1 family member, Fra-1, via a mitogen-activated protein/extracellular signal-regulated kinase-dependent pathway. We also show that PI3-kinase signaling is required for the motility of HCT116 cells downstream of oncogenic K-Ras. Our findings suggest that mutated K-RAS oncogenes are essential for maintenance of the transformed and invasive phenotype of human colon cancer cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15735008     DOI: 10.1158/0008-5472.CAN-04-1911

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  56 in total

1.  Fra-1 promotes growth and survival in RAS-transformed thyroid cells by controlling cyclin A transcription.

Authors:  Laura Casalino; Latifa Bakiri; Francesco Talotta; Jonathan B Weitzman; Alfredo Fusco; Moshe Yaniv; Pasquale Verde
Journal:  EMBO J       Date:  2007-03-08       Impact factor: 11.598

2.  Ras Signaling in Breast Cancer.

Authors:  Aree Moon
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Ras transformation uncouples the kinesin-coordinated cellular nutrient response.

Authors:  Elma Zaganjor; Lauren M Weil; Joshua X Gonzales; John D Minna; Melanie H Cobb
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-07       Impact factor: 11.205

Review 4.  PI3K: A Crucial Piece in the RAS Signaling Puzzle.

Authors:  Agata Adelajda Krygowska; Esther Castellano
Journal:  Cold Spring Harb Perspect Med       Date:  2018-06-01       Impact factor: 6.915

5.  Oncogenic ras-induced down-regulation of autophagy mediator Beclin-1 is required for malignant transformation of intestinal epithelial cells.

Authors:  Byong Hoon Yoo; Xue Wu; Yongling Li; Mehnaaz Haniff; Takehiko Sasazuki; Senji Shirasawa; Eeva-Liisa Eskelinen; Kirill V Rosen
Journal:  J Biol Chem       Date:  2009-09-24       Impact factor: 5.157

6.  Combination of MEK Inhibitor and the JAK2-STAT3 Pathway Inhibition for the Therapy of Colon Cancer.

Authors:  Jianying Jin; Qunyi Guo; Jingjing Xie; Dan Jin; Yanan Zhu
Journal:  Pathol Oncol Res       Date:  2019-01-31       Impact factor: 3.201

7.  A Fra-1-dependent, matrix metalloproteinase driven EGFR activation promotes human lung epithelial cell motility and invasion.

Authors:  Pavan Adiseshaiah; Michelle Vaz; Narsa Machireddy; Dhananjaya V Kalvakolanu; Sekhar P Reddy
Journal:  J Cell Physiol       Date:  2008-08       Impact factor: 6.384

8.  PDLIM4, an actin binding protein, suppresses prostate cancer cell growth.

Authors:  Donkena Krishna Vanaja; Michael E Grossmann; John C Cheville; Mozammel H Gazi; Aiyu Gong; Jin San Zhang; Katalin Ajtai; Thomas P Burghardt; Charles Y F Young
Journal:  Cancer Invest       Date:  2009-03       Impact factor: 2.176

9.  PAK is regulated by PI3K, PIX, CDC42, and PP2Calpha and mediates focal adhesion turnover in the hyperosmotic stress-induced p38 pathway.

Authors:  Perry M Chan; Louis Lim; Edward Manser
Journal:  J Biol Chem       Date:  2008-06-27       Impact factor: 5.157

10.  Critical role of the WASF3 gene in JAK2/STAT3 regulation of cancer cell motility.

Authors:  Yong Teng; Pushpankur Ghoshal; Lambert Ngoka; Yun Mei; John K Cowell
Journal:  Carcinogenesis       Date:  2013-05-14       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.